Using such approach, we detected a large amplification which included both YAP1 and CCND1 genes in 16/77 (21%) NSCLC samples, while 2/77 samples (2.6%) carried an amplification restricted to YAP1 (Figure 1e). The gene discussed is CCND1; the disease is non-small cell lung carcinoma.